Target intelligence / Profile preview

Hepatitis B virus preS domain of envelope protein (preS)

Target
preS
Molecular classification
Viral protein domain, Viral attachment/fusion domain, Other
01

Overview

The **preS domain** of the hepatitis B virus (HBV) envelope protein is a composite region comprising two contiguous segments—preS1 (N-terminal) and preS2 (central)—which, together with the S (small) domain, form the large (L) envelope protein of HBV[1][2][9]. These domains are *essential for viral infectivity*, as the N-terminal residues of preS1 (approximately the first 48 amino acids) mediate **binding to the viral receptor sodium taurocholate co-transporting polypeptide (NTCP)** on hepatocytes, initiating infection[1][2][9]. The preS region also participates in virus assembly, notably at the preS1/preS2 junction, where interactions with the viral capsid occur during particle formation[1][3]. Myristoylation at the N-terminus of preS1 is crucial for receptor interaction and membrane insertion during infection[2]. In addition, the preS domain is a principal target for neutralizing antibodies and entry inhibitors—such as bulevirtide—which block HBV entry by mimicking the NTCP-binding function of preS1[2]. Mutagenesis of the preS domains affects infectivity, morphogenesis, and immune recognition, implicating this region in disease progression, immune evasion, and antiviral resistance[1][2][5]. Chronic infection by HBV facilitated by preS-mediated attachment can lead to serious liver diseases, including hepatic inflammation and hepatocellular carcinoma[4]. **Key points:** - The preS domain is not a human gene product, but a viral protein domain vital for HBV life cycle and pathogenesis. - Its functions span **host cell receptor binding, membrane fusion, virion assembly, and immune evasion**. - It is the molecular target for entry inhibitors, notably **bulevirtide**, used clinically for hepatitis B and D treatment. - Variants or mutations in preS are relevant for vaccine design, drug resistance, and disease monitoring[2][5].

Other names
preS domainpreS1 domainpreS2 domainLarge envelope protein domainL protein preS
02

Mechanism of action

Inhibition of viral entry via blocking preS1-NTCP interaction

03

Biological functions

Viral attachment to host cellMediation of viral entry (receptor binding and membrane fusion)Viral assembly (interaction with capsid)Immune evasion
04

Disease associations

Infection (central to hepatitis B virus infection)Cancer (chronic HBV infection promotes hepatocellular carcinoma)Other (liver inflammation)
05

Safety considerations

Potential for immune-driven liver inflammation with vaccines or antibody-based therapiesResistance due to preS mutations in chronic HBV
06

Interacting drugs

Bulevirtide (Hepcludex/myrcludex B; a peptide entry inhibitor)
07

Biomarkers

Antibodies to preS in patient sera as evidence of infection or immunityDetection of preS mutations for drug resistance or escape variants

Beyond the preview

Go deeper on Hepatitis B virus preS domain of envelope protein (preS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus preS domain of envelope protein (preS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call